Trial intelligence / Profile preview

Triglide in primary biliary cirrhosis

NCT00575042Phase 2Completed

Sponsor
University of Florida
Start
Aug 2007
Primary completion
Aug 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of fenofibrate in primary biliary cholangitis (PBC), sponsored by University of Florida. Primary endpoints: Alkaline Phosphatase at 1 year and Immunoglobulin M at 1 year. Started Aug 2007; status: completed.

02

Drugs

fenofibrate
03

Conditions

primary biliary cholangitis (PBC)

Beyond the preview

Go deeper on NCT00575042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00575042.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call